Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
Podcast - Inside Telehealth's Growth, Regulation and Access
Health-e Law Podcast, Episode 25 | Human-in-the-Loop: Bringing AI to Skilled Nursing Facilities
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 274: Advancing Cancer Immunotherapy with Dr. Besim Ogretmen of Lipo-Immuno Tech & MUSC
False Claims Act Insights - Healthcare Compensation and Referrals: Avoiding Compliance Pitfalls in Physician Deals
DOJ’s Bulk Sensitive Data Transfer Rule: Key Insights for Health Care Compliance Teams – Diagnosing Health Care
Hospice Insights Podcast - High Risk Hospices Are in the Hot Seat Across Six States
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 273: Navigating FDA Regulation for Life Sciences Companies with Christin Carey of Maynard Nexsen
PODCAST – 2026 To Do: HIPAA Compliance
2026 To Do: HIPAA Compliance
Health-E Law Podcast, Episode 24 | ViVE 2026: AI and the Future of Healthcare
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 272: Humanism and Transplant Care with Dr. Joseph Scalea of MUSC
So, you need to file a Medicaid application to secure Medicaid benefits for someone who is incapacitated or incompetent – someone who, due to mental and/or physical impairments, lacks sufficient understanding or capacity to...more
Another Food and Drug Law Institute (FDLI) Annual Conference is in the books, and the Food and Drug Administration’s (FDA) messaging at the 2026 edition blended big-picture aspirations with clear near-term change. Right from...more
A Canadian Study published on-line in January 2026 by the Journal of the American Medical Association, JAMA Network Open, finds that a history of prior concussion is associated with a 15% increase in the risk of long-term...more
On April 14, 2026, the United States Food and Drug Administration (“FDA”) issued a draft guidance for sponsors seeking approval of human gene-editing therapy products involving gene-editing technologies. ...more
In April 2026, the U.S. Department of Justice (DOJ) and Drug Enforcement Administration (DEA) announced a significant shift in federal cannabis policy. Effective immediately, the following categories of marijuana have been...more
For years, cannabis operators have functioned under a fundamentally distorted tax regime. Section 280E denied deductions that every other business takes for granted, forcing companies to pay tax on something closer to gross...more
Senate Health, Education, Labor, and Pensions (HELP) Committee Chair Cassidy convened two healthcare hearings in Louisiana in advance of his Senate primary on May 16, 2026. He was the only committee member in attendance....more
Recent developments suggest that major health care and life sciences organizations are expanding their use of AI beyond trial initiatives and targeted applications, while federal and state policymakers struggle to develop...more
On April 22, 2026, Acting Attorney General Todd Blanche issued a final order immediately placing both FDA-approved marijuana products and state-regulated medical marijuana products in Schedule III of the Controlled Substances...more
On May 1, 2026, CMS published three interconnected Federal Register notices that set the stage for how Medicare will price clinical laboratory tests in calendar year 2027. They announce the rechartering and new membership of...more
News Briefs - Administration Exempts Foreign Doctors From Travel Ban - Foreign doctors will be able to receive visas allowing them to practice in the United States, after the Trump administration quietly changed a policy to...more
The U.S. Food and Drug Administration (FDA) announced a “real-time clinical trials” (RTCT) pilot program to permit agency reviewers to review study data simultaneously with its collection by investigators. FDA also issued an...more
Overview of Additions to CCL 6 - On April 2, 2026, the United States Environmental Protection Agency (EPA) announced that per- and polyfluoroalkyl substances (PFAS), microplastics, pharmaceuticals, and disinfection...more
For AI-based medical devices (AIMDs), one of the crucial questions arising is how to ensure that users of the AIMD (e.g., physicians) can still ultimately oversee and steer diagnostic and treatment decisions. In response to...more
Last week, Connecticut’s legislature passed a bill to amend the state’s consumer data privacy law and establish a data broker registration law, Iowa’s governor signed a chatbot bill into law, Colorado’s legislature passed a...more
On May 7, 2026, Ohio Attorney General (AG) Dave Yost announced his resignation after having served in the role since 2019. Yost’s resignation is effective at midnight on June 7, 2026. Yost is vacating his position to join...more
The U.S. Centers for Medicare and Medicaid Services (CMS) recently hosted its “HealthTech Ecosystem Live! First Wave” Launch, during which the agency announced the first apps that it is recommending to Medicare through the...more
228 Hours and Counting… As of noon on Friday, May 8, there will be exactly 228 hours left in the 2026 Legislative Session before the required Constitutional adjournment deadline of midnight on Monday, May 18. With this...more
Key Takeaways - The closure of the Strait of Hormuz following the U.S.-Iran conflict is disrupting global health care supply chains and increasing costs for critical medical products....more
Key Takeaways - The Centers for Medicare and Medicaid Services has directed states to expedite Medicaid provider revalidation, requiring two-year revalidation strategies within 30 days and focusing on high-risk providers not...more
Department of Justice (DOJ) announced the Fraud Oversight through Careful Use of Statistics (FOCUS) Initiative on April 30, 2026, a new effort designed to increase False Claims Act (FCA) enforcement through partnerships with...more
Key Takeaways - The Food & Drug Administration issued a Warning Letter citing a drug company for inappropriate use of AI in pharmaceutical manufacturing, marking what appears to be the first time the agency has specifically...more
Fashion, beauty, and wearable technology brands are heading into 2026 with a lot more to think about concerning data privacy. What used to feel like a back-end legal issue is now shaping how companies design products,...more
On April 23, 2026, the Food and Drug Administration (FDA) and Centers for Medicare & Medicaid Services (CMS) jointly announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway....more
Pharmacy Benefit Manager (“PBM”) arrangements have long relied on rebates with limited transparency into true drug costs. Recent regulatory and market developments represent a shift toward greater transparency and better net...more